(Q34637205)

3 August 2017

title

Probiotics in the intensive care unit. (English)

1 reference

3 August 2017

0 references

1 reference

Lee E Morrow

1

1 reference

3 August 2017

Vijaya Gogineni

series ordinal

2

1 reference

3 August 2017

Mark A Malesker

series ordinal

3

1 reference

3 August 2017

publication date

1 April 2012

1 reference

Nutrition in Clinical Practice

3 August 2017

published in

1 reference

3 August 2017

volume

27

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

235-241

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

3 August 2017

1 reference

PROBIOTICS: GROWTH-PROMOTING FACTORS PRODUCED BY MICROORGANISMS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Probiotic bacteria and intestinal epithelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Comparative study of the intestinal mucus barrier in normal and inflamed colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Innate and adaptive mechanisms to control [corrected] pathological intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Structural and functional diversity of microcins, gene-encoded antibacterial peptides from enterobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Characterization of the genetic locus responsible for the production of ABP-118, a novel bacteriocin produced by the probiotic bacterium Lactobacillus salivarius subsp. salivarius UCC118.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Antimicrobial activity of lacticin 3,147 against clinical Clostridium difficile strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Effect of probiotic strains on interleukin 8 production by HT29/19A cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Functional modulation of enterocytes by gram-positive and gram-negative microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

The inflammatory status of old age can be nurtured from the intestinal environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Systematic review and meta-analysis of Saccharomyces boulardii in adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

The Effect of Antibiotic and Probiotic Combination Therapy on Secondary Pancreatic Infections and Oxidative Stress Parameters in Experimental Acute Necrotizing Pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Effects of probiotics on the severity of experimental acute pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Comparison of early enteral nutrition in severe acute pancreatitis with prebiotic fiber supplementation versus standard enteral solution: a prospective randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Intraoperative splanchnic hypoperfusion, increased intestinal permeability, down-regulation of monocyte class II major histocompatibility complex expression, exaggerated acute phase response, and sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Probiotic bacteria enhance murine and human intestinal epithelial barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Altered gut flora and environment in patients with severe SIRS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

[Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery - results of a prospective trial].

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Lactobacillus probiotic use in cardiothoracic transplant recipients: a link to invasive Lactobacillus infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

Probiotics for prevention of antibiotic-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533612440290

21 January 2018

Identifiers

DOI

10.1177/0884533612440290

1 reference

3 August 2017

1 reference